Clinical trial
A Phase I Clinical Trial to Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With Amyotrophic Lateral Sclerosis
NCT06676423 is registered in ClinicalTrials.gov with Corestemchemon, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Clinical Trial to Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With Amyotrophic Lateral Sclerosis
- Lead sponsor
- Corestemchemon, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 9, 2022
- Completion date
- November 27, 2023
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.